Navigation Links
Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
Date:5/5/2008

lar Biology and Genetics from the University of Guelph and completed a three-year post-doctoral training program at the University of Michigan. He joined Lorus through the merger with GeneSense Technologies Inc. in 1999, where he was a Research Scientist involved in the GeneSense oligonucleotide therapeutics program. He has authored many scientific publications and is also an author of numerous patents and conference proceedings.

"I am delighted to promote these two experienced professionals to our senior management team", said Dr. Aiping Young, Lorus' President and CEO. "Their skills and knowledge will allow us to progress our novel anticancer drugs towards commercialization and seize emerging opportunities to accelerate the growth of our business."

About Lorus

Lorus is a biopharmaceutical company focused on the research and development of novel therapeutics in cancer. Lorus' goal is to capitalize on its research, preclinical, clinical and regulatory expertise by developing new drug candidates that can be used, either alone, or in combination with other drugs, to successfully manage cancer. Through its own discovery efforts and an acquisition and in-licensing program, Lorus is building a portfolio of promising anticancer drugs. Lorus Therapeutics Inc. is listed on the Toronto Stock Exchange under the symbol LOR, and on the American Stock Exchange under the symbol LRP.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Canadian and U.S. securities laws. Such statements include, but are not limited to, statements relating to: financings and corporate reorganizations, the establishment of corporate alliances, the Company's plans, objectives, expectations and intentions and other statements including words such as "continue", "expect", "intend", "will", "should", "would", "may", and other similar expressions. Such statements reflect our current views with respect to future events an
'/>"/>

SOURCE Lorus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
2. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
3. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
4. Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040
5. Lorus initiates development program exploring novel route of administration for LOR-2040
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... IL (PRWEB) May 23, 2013 Bed bugs ... against the pests is still ongoing, a report from kmov.com ... more for the bed bug treatment. Meanwhile, to be of ... apartment from the costly bed bug exterminator service. ... stated that AHA has so far spent $35,000 ...
(Date:5/23/2013)... Newmarket, NH (PRWEB) May 23, 2013 Ralph ... all of their emergency management products and emergency survival ... , This announcement was made at the quarterly executive ... meeting with a moment of silence for the Oklahoma tornado ... executives that the quality of their emergency kits is paramount. ...
(Date:5/22/2013)... 2013 Industry leaders from around ... the Oak Ridge National Laboratory’s Biosurveillance Symposium ... at the Hilton Alexandria Mark Center. Held in ... conference on June 18 - 19. , ... American Elements, Applied Research Associates, ARA, AttaGene, Battelle, ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The ... Annual Disruptive Innovations to Advance Clinical Trials conference taking ... Hotel in Boston, MA. , Disruptive thinkers from ... and more share bold approaches to reduce expensive infrastructure, ... “Disruptive innovation needs to be big, or novel, or ...
Breaking Biology Technology:Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2PHI Emergency Management on Announces Father's Day Specials All Emergency Survival Kits 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 3Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 4Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 5Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2
... 11:00 am EASTERN, DUBLIN, Ireland, July 15 ... and manufacturer of diagnostic products,for the point-of-care and clinical ... of fiscal year 2008 on Tuesday,July 22, 2008. The ... Tuesday, July 22, 2008, at 11:00am EDT (4:00pm BST) ...
... of Group Purchasing Organizations Hosted,by Trane -, ... Society of,Healthcare Engineering (ASHE) offers professional learning opportunities,for ... is no exception. Added,to the roster for the ... of,indoor comfort systems and comprehensive facility solutions., ...
... SHANGHAI, China, July 15 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. ... leading Chinese firm specializing in the manufacture,research, ... announced the appointment of American Stock Transfer ... agent and registrar, effective August 15, 2008.,AST, ...
Cached Biology Technology:Trinity Biotech plc to Announce Second Quarter 2008 Financial Results on July 22, 2008 2Healthcare Facility Managers Learn to Optimize Surgical Suites at 2008 ASHE Annual Conference 2Healthcare Facility Managers Learn to Optimize Surgical Suites at 2008 ASHE Annual Conference 3China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008 2
(Date:5/23/2013)... cancer patients unnecessarily undergo surgery or harsh treatments ... slow-growing and aggressive forms of the disease. Researchers ... Medical Institutes are developing technology that allows patients ... relatively mild treatments or take drastic measures. , ... an associate professor of biomedical engineering at Case ...
(Date:5/23/2013)... history museums of the world are billions of animal ... flowers, mushrooms and grasses, all stacked, stored and preserved ... diverse collections could be critical to understanding how the ... growing human footprint if only the information were ... life with the help of a team from the ...
(Date:5/23/2013)... age when microbial pathogens are growing increasingly resistant to ... team of Wisconsin scientists has synthesized a potent new ... cause staph infections. , Writing online in the ... led by University of Wisconsin-Madison chemistry Professor Helen Blackwell ... behavior of Staphylococcus aureus , a bacterium at ...
Breaking Biology News(10 mins):Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4University of Wisconsin chemists find new compounds to curb staph infection 2
... team from Rollins College in Florida and the University of ... coral-killing pathogen that causes white pox disease of Caribbean elkhorn ... coral was listed for protection under the United States Endangered ... The team,s findings have just been published in the peer-reviewed ...
... -- in particular, dog fecal material -- may constitute the ... air, says a new University of Colorado Boulder study. ... cities in the experiment, two cities had significant quantities of ... the most likely source. "We found unexpectedly high ...
... helpful even life-saving to have a warning sign before ... few nanometers in size, having a sign that,s easy to read ... molecular design by University of Pennsylvania and Duke University bioengineers and ... color change. The study was conducted by ...
Cached Biology News:Human pathogen killing corals in the Florida Keys 2Human pathogen killing corals in the Florida Keys 3New CU-Boulder study reveals bacteria from dog feces in outdoor air of urbanized air 2New CU-Boulder study reveals bacteria from dog feces in outdoor air of urbanized air 3Penn molecular scientists develop color-changing stress sensor 2Penn molecular scientists develop color-changing stress sensor 3